Scoring system and management algorithm assessing the role of survivin expression in predicting progressivity of HPV infections in precancerous cervical lesions

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 3, 2013, Pages 1643-1647

  Indarti, Junita ^a   Farid Aziz, M ^a   Suryawati, Bethy ^b   Fernando, Darrell ^c  

^a CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^b PADJADJARAN UNIVERSITY   (Indonesia)

^c UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Cervical intraepithelial neoplasia; Immunocytochemistry; Precancerous cervical lesions; Survivin

Indexed keywords

EID: 84880407733     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.3.1643     Document Type: Article

References (24)

1. Almonte M, Ferreccio C, Gonzales M (2011). Risk factors for high-risk human papillomavirus infection and cofactors for high-grade cervical disease in Peru. Int J Gynecol Cancer, 21, 1654-63.
2. American Cancer Society (2009). What Are the Risk Factors for Cervical Cancer? Available at http://www.cancer.org/cancer/ cervicalcancer/detailedguide/cervical-cancer-risk-factors. Accessed July 14, 2010.
3. Barbosa LC, da Silva ID, Correa JC, Ribalta JC (2011). Survivin and telomerase expression in the uterine cervix of women with human papillomavirus-induced lesions. Int J Gynecol Cancer, 21, 15-21.
4. Belinson S, Smith JS, Myers E, et al (2008). Descriptive evidence that risk profiles for cervical intraepithelial neoplasia 1, 2, and 3 are unique. Cancer Epidemiol Biomarkers Prev, 17, 2350-5.
5. Bibbo M, Klump WJ, DeCecco J, Kovatich AJ (2002). Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens. Acta Cytol, 46, 25-9.
6. Boone JD, Erickson BK, Huh WK (2012). New insights to cervical cancer screening. J Gynecol Oncol, 23, 282-7.
7. Borbely AA, Murvai M, Konya J et al (2006). Effects of human papillomavirus type 16 oncoproteins on survivin gene expression. J Gen Virol, 87, 287-94.
8. Branca M, Giorgi C, Santini D, et al (2005). Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol, 124, 113-21.
9. Branca M, Ciotti M, Giorgi C et al (2008). Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling. Int J Gynecol Pathol, 27, 265-73.
10. Castle PE, Cox JT, Schiffman M WC, Solomon D (2008). Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology. Obstet Gynecol, 112, 637-45.
11. de Boer MA, Vet JN, Aziz MF et al (2006). Human papillomavirus type 18 and other risk factors for cervical cancer in Jakarta, Indonesia. Int J Gynecol Cancer, 16, 1809-14.
12. Engberts MK, Verbruggen BS, Boon ME, van Haaften M, Heintz AP (2007). Candida and dysbacteriosis: a cytologic, population-based study of 100,605 asymptomatic women concerning cervical carcinogenesis. Cancer, 111, 269-74.
13. Gadducci A, Barsotti C, Cosio S, Domenici L, Riccardo GA (2011). Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature. Gynecol Endocrinol, 27, 597-604.
14. Gillet E, Meys JFA, Verstraelen H, et al (2012). Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and metaanalysis. PLoS One, 7, 45201.
15. Hellberg D, Stendahl U (2005). The biological role of smoking, oral contraceptive use and endogenous sexual steroid hormones in invasive squamous epithelial cervical cancer. Anticancer Res, 25, 3041-6.
16. Jensen KE, Schmiedel S, Norrild B et al (2013). Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up. Br J Cancer, 108, 234-9.
17. Kim JW, Song SH, Jin CH, et al (2012). Factors affecting the clearance of high-risk human papillomavirus infection and the progression of cervical intraepithelial neoplasia. J Int Med Res, 40, 486-96.
18. Kim K, Kim JJ, Kim SM, No JH, Kim YB (2012). Prevalence and determinants of high-risk human papillomavirus infection in women with high socioeconomic status in Seoul, Republic of Korea. Asian Pac J Cancer Prev, 13, 269-73.
19. Li F (2005). Role of survivin and its splice variants in tumorigenesis. Br J Cancer, 92, 212-6.
20. Mita AC, Mita MM, Nawrocki ST, Giles FJ (2008). Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res, 14, 5000-5.
21. Poomtavorn Y, Suwannarurk K, Thaweekul Y, Maireang K (2011). Risk factors for high-grade cervical intraepithelial neoplasia in patients with atypical squamous cells of undetermined significance (ASC-US) Papanicolaou smears. Asian Pac J Cancer Prev, 12, 235-8.
22. Roeters AM, Boon ME, van Haaften M, et al (2010). Inflammatory events as detected in cervical smears and squamousintraepithelial lesions. Diagn Cytopathol, 38, 85-93.
23. Tan GC, Norlatiffah S, Sharifah NA et al (2010). Immunohistochemical study of p16 INK4A and survivin expressions in cervical squamous neoplasm. Indian J Pathol Microbiol, 53, 1-6.
24. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) (2010). Human Papillomavirus and Related Cancers in Indonesia. Summary Report 2010. Accessed 5 February 2013.